The global single-use assemblies market size was accounted at USD 13.52 billion in 2024 and it is projected to hit around USD 61.20 billion by 2034, growing at a CAGR of 16.3% from 2025 to 2034. The market growth is driven by the growing demand for biologics and personalized medicines, the Single-use Assemblies Market is experiencing robust growth.
Report Coverage | Details |
Market Size in 2024 | USD 13.52 billion |
Revenue Forecast by 2034 | USD 61.20 billion |
Growth rate from 2025 to 2034 | CAGR of 16.3% |
Base Year | 2024 |
Forecast Period | 2025 to 2034 |
Regions | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Covered | Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Danaher Corporation (Cytiva and Pall Corporation), Saint-Gobain Life Sciences, Repligen Corporation, Parker Hannifin Corporation, Avantor, Inc., Entegris, Inc., Corning Incorporated |
The global single-use assemblies market has witnessed significant growth in recent years, driven by increasing adoption of single-use technologies in biopharmaceutical manufacturing. These assemblies, which include tubing, connectors, filters, and sensors, are pre-assembled and sterilized for immediate use, reducing the risk of contamination and cross-contact. They offer operational flexibility, lower labor costs, and faster turnaround times, making them ideal for small-batch and multi-product facilities. With the growing demand for biologics, vaccine, and cell and gene therapies, single-use assemblies are becoming indispensable in streamlining production processes and maintaining high standards of sterility and quality assurance.
The growth of the single-use assemblies market is primarily driven by the rising demand for biopharmaceuticals, including monoclonal antibodies, vaccines, and cell and gene therapies. As these therapies often require highly sterile and flexible manufacturing environments, single-use assemblies provide an ideal solution by reducing the risk of cross-contamination and eliminating the need for extensive cleaning procedures. This not only improves operational efficiency but also accelerates the production timeline, which is critical for time-sensitive therapies.
Another key growth factor is the increasing reliance on contract research organizations (CROs) and contract manufacturing organizations (CMOs), which often utilize single-use systems to enhance scalability and lower production costs. These assemblies also support the shift toward small-batch and personalized medicine production, where traditional stainless-steel systems may lack the required flexibility.
One of the primary challenges faced by the single-use assemblies market is the environmental impact associated with the disposal of plastic-based components. Since these systems are designed for one-time use, they generate substantial amounts of biomedical and plastic waste, raising concerns around sustainability and regulatory compliance. While efforts are being made to develop recyclable or biodegradable materials, the industry still lacks standardized protocols for waste management and recycling.
Another significant challenge is the risk of supply chain disruptions and quality inconsistencies. The single-use assemblies market heavily relies on specialized components and materials, and any delay or shortage can significantly impact biomanufacturing timelines. Moreover, ensuring product compatibility and consistent quality across different batches and suppliers remains a hurdle. Regulatory requirements for validation and documentation are also stringent, especially when switching suppliers or integrating new materials, adding further complexity.
North America held the largest share of the regional market in 2024, accounting for 38% of the total revenue. North America held the largest share of the global single-use assemblies market, primarily driven by the strong presence of leading biopharmaceutical companies, advanced healthcare infrastructure, and high investment in R&D activities. The region benefits from early adoption of innovative bioprocessing technologies, stringent regulatory standards, and a mature ecosystem of contract manufacturing organizations. The United States, in particular, plays a crucial role due to its well-established biologics production capabilities and growing demand for cell and gene therapies.
The Asia Pacific region is projected to witness the fastest growth during the forecast period. This expansion is fueled by the rapid development of biopharmaceutical infrastructure, favorable government initiatives, and rising investments by global pharmaceutical companies in countries such as China, India, and South Korea. The increasing prevalence of chronic diseases, expanding patient populations, and growing clinical trial activity in the region also contribute to the rising demand for cost-effective and scalable single-use solutions.
The filtration assemblies segment accounted for the largest share of the overall revenue, contributing 29% in 2024. These assemblies are essential for removing particulates, bacteria, and other impurities during upstream and downstream processing, ensuring product purity and safety. Filtration assemblies offer several advantages, including reduced risk of cross-contamination, shorter turnaround times, and minimal validation requirements. As biomanufacturers strive to enhance operational efficiency and maintain high-quality standards, the demand for pre-validated, ready-to-use filtration assemblies continues to grow.
The bag assemblies segment is projected to register the highest CAGR during the forecast period from 2025 to 2034. These assemblies are typically composed of multi-layer polymer films that ensure high levels of strength, flexibility, and sterility. Their adoption reduces the need for cleaning and sterilization, offering cost and time savings to manufacturers. Bag assemblies are particularly beneficial in modular and flexible manufacturing facilities, where speed and adaptability are crucial.
The filtration segment led the market, capturing the highest revenue share of 29% in 2024. Single-use filtration assemblies help in removing impurities, particulates, and microorganisms from process fluids to ensure product sterility and integrity. These systems are commonly utilized in both upstream and downstream processes, including harvest clarification, viral filtration, and final fill-finish steps. The use of disposable filtration assemblies minimizes the risk of cross-contamination, reduces cleaning validation efforts, and enhances overall process efficiency.
The cell culture and mixing segment is projected to experience the highest CAGR during the forecast period from 2025 to 2034. These assemblies are essential for cultivating cells in a controlled environment and for the consistent mixing of media, buffers, and other process fluids. Single-use systems provide flexible, closed-loop environments that maintain sterility while supporting high cell viability and productivity. Their use significantly reduces the setup time and operational complexities compared to traditional stainless-steel systems.
The customized solutions segment led the global industry in 2024, capturing the largest share of 72% in 2024. These solutions are developed in close collaboration with end-users to ensure compatibility with existing systems, optimize workflow, and meet regulatory and operational standards. The flexibility to modify tubing lengths, connectors, filtration units, and other components makes customized assemblies ideal for complex bioprocessing needs, including multi-product and small-batch production environments.
Standard solutions, on the other hand, are gaining popularity for their cost-effectiveness, quick deployment, and ease of integration in less complex manufacturing environments. These pre-configured assemblies are designed to meet general bioprocessing needs and are readily available, which helps reduce procurement timelines and supports faster facility startup. Standard solutions are particularly beneficial for small and mid-sized companies or for early-stage production where rapid implementation is essential. While they may offer less flexibility compared to customized assemblies, advancements in standardization and modular design have significantly improved their performance and adaptability.
The biopharmaceutical and pharmaceutical companies segment dominated the global industry, contributing the highest share of 50% to the overall revenue in 2024. These companies rely on single-use assemblies to maintain sterility, reduce downtime, and increase process flexibility. The adoption of single-use systems enables faster changeovers, minimizes cleaning and validation requirements, and supports the production of high-value biologics such as monoclonal antibodies, cell and gene therapies, and vaccines.
The CROs and CMOs segment is anticipated to record the fastest CAGR throughout the forecast period. These service providers play a critical role in outsourcing strategies adopted by biopharma companies, offering flexible and scalable manufacturing capabilities. Single-use assemblies allow CROs and CMOs to manage multiple client projects with varying process requirements while minimizing cross-contamination risks and operational turnaround times. The demand for these assemblies among CROs and CMOs is further fueled by the rise in clinical trials, especially for biologics and personalized medicine.
By Product
By Application
By Solution
By End-use
By Regional
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Single-use Assemblies Market
5.1. COVID-19 Landscape: Single-use Assemblies Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Single-use Assemblies Market, By Product
8.1. Single-use Assemblies Market, by Product, 2025-2034
8.1.1. Bag Assemblies
8.1.1.1. Market Revenue and Forecast (2025-2034)
8.1.2. Filtration Assemblies
8.1.2.1. Market Revenue and Forecast (2025-2034)
8.1.3. Bottle Assemblies
8.1.3.1. Market Revenue and Forecast (2025-2034)
8.1.4. Tubing Assemblies
8.1.4.1. Market Revenue and Forecast (2025-2034)
8.1.5. Other Products
8.1.5.1. Market Revenue and Forecast (2025-2034)
Chapter 9. Global Single-use Assemblies Market, By Application
9.1. Single-use Assemblies Market, by Application, 2025-2034
9.1.1. Filtration
9.1.1.1. Market Revenue and Forecast (2025-2034)
9.1.2. Cell Culture & Mixing
9.1.2.1. Market Revenue and Forecast (2025-2034)
9.1.3. Storage
9.1.3.1. Market Revenue and Forecast (2025-2034)
9.1.4. Sampling
9.1.4.1. Market Revenue and Forecast (2025-2034)
9.1.5. Fill-finish Applications
9.1.5.1. Market Revenue and Forecast (2025-2034)
9.1.6. Other Applications
9.1.6.1. Market Revenue and Forecast (2025-2034)
Chapter 10. Global Single-use Assemblies Market, By Solution
10.1. Single-use Assemblies Market, by Solution, 2025-2034
10.1.1. Customized Solutions
10.1.1.1. Market Revenue and Forecast (2025-2034)
10.1.2. Standard Solutions
10.1.2.1. Market Revenue and Forecast (2025-2034)
Chapter 11. Global Single-use Assemblies Market, By End-user
11.1. Single-use Assemblies Market, by End-user, 2025-2034
11.1.1. Biopharmaceutical & Pharmaceutical Companies
11.1.1.1. Market Revenue and Forecast (2025-2034)
11.1.2. CROs & CMOs
11.1.2.1. Market Revenue and Forecast (2025-2034)
11.1.3. Academic & Research Institutes
11.1.3.1. Market Revenue and Forecast (2025-2034)
Chapter 12. Global Single-use Assemblies Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2025-2034)
12.1.2. Market Revenue and Forecast, by Application (2025-2034)
12.1.3. Market Revenue and Forecast, by Solution (2025-2034)
12.1.4. Market Revenue and Forecast, by End-user (2025-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2025-2034)
12.1.5.2. Market Revenue and Forecast, by Application (2025-2034)
12.1.5.3. Market Revenue and Forecast, by Solution (2025-2034)
12.1.5.4. Market Revenue and Forecast, by End-user (2025-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2025-2034)
12.1.6.2. Market Revenue and Forecast, by Application (2025-2034)
12.1.6.3. Market Revenue and Forecast, by Solution (2025-2034)
12.1.6.4. Market Revenue and Forecast, by End-user (2025-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2025-2034)
12.2.2. Market Revenue and Forecast, by Application (2025-2034)
12.2.3. Market Revenue and Forecast, by Solution (2025-2034)
12.2.4. Market Revenue and Forecast, by End-user (2025-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2025-2034)
12.2.5.2. Market Revenue and Forecast, by Application (2025-2034)
12.2.5.3. Market Revenue and Forecast, by Solution (2025-2034)
12.2.5.4. Market Revenue and Forecast, by End-user (2025-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2025-2034)
12.2.6.2. Market Revenue and Forecast, by Application (2025-2034)
12.2.6.3. Market Revenue and Forecast, by Solution (2025-2034)
12.2.6.4. Market Revenue and Forecast, by End-user (2025-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2025-2034)
12.2.7.2. Market Revenue and Forecast, by Application (2025-2034)
12.2.7.3. Market Revenue and Forecast, by Solution (2025-2034)
12.2.7.4. Market Revenue and Forecast, by End-user (2025-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2025-2034)
12.2.8.2. Market Revenue and Forecast, by Application (2025-2034)
12.2.8.3. Market Revenue and Forecast, by Solution (2025-2034)
12.2.8.4. Market Revenue and Forecast, by End-user (2025-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2025-2034)
12.3.2. Market Revenue and Forecast, by Application (2025-2034)
12.3.3. Market Revenue and Forecast, by Solution (2025-2034)
12.3.4. Market Revenue and Forecast, by End-user (2025-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2025-2034)
12.3.5.2. Market Revenue and Forecast, by Application (2025-2034)
12.3.5.3. Market Revenue and Forecast, by Solution (2025-2034)
12.3.5.4. Market Revenue and Forecast, by End-user (2025-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2025-2034)
12.3.6.2. Market Revenue and Forecast, by Application (2025-2034)
12.3.6.3. Market Revenue and Forecast, by Solution (2025-2034)
12.3.6.4. Market Revenue and Forecast, by End-user (2025-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2025-2034)
12.3.7.2. Market Revenue and Forecast, by Application (2025-2034)
12.3.7.3. Market Revenue and Forecast, by Solution (2025-2034)
12.3.7.4. Market Revenue and Forecast, by End-user (2025-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2025-2034)
12.3.8.2. Market Revenue and Forecast, by Application (2025-2034)
12.3.8.3. Market Revenue and Forecast, by Solution (2025-2034)
12.3.8.4. Market Revenue and Forecast, by End-user (2025-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2025-2034)
12.4.2. Market Revenue and Forecast, by Application (2025-2034)
12.4.3. Market Revenue and Forecast, by Solution (2025-2034)
12.4.4. Market Revenue and Forecast, by End-user (2025-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2025-2034)
12.4.5.2. Market Revenue and Forecast, by Application (2025-2034)
12.4.5.3. Market Revenue and Forecast, by Solution (2025-2034)
12.4.5.4. Market Revenue and Forecast, by End-user (2025-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2025-2034)
12.4.6.2. Market Revenue and Forecast, by Application (2025-2034)
12.4.6.3. Market Revenue and Forecast, by Solution (2025-2034)
12.4.6.4. Market Revenue and Forecast, by End-user (2025-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2025-2034)
12.4.7.2. Market Revenue and Forecast, by Application (2025-2034)
12.4.7.3. Market Revenue and Forecast, by Solution (2025-2034)
12.4.7.4. Market Revenue and Forecast, by End-user (2025-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2025-2034)
12.4.8.2. Market Revenue and Forecast, by Application (2025-2034)
12.4.8.3. Market Revenue and Forecast, by Solution (2025-2034)
12.4.8.4. Market Revenue and Forecast, by End-user (2025-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2025-2034)
12.5.2. Market Revenue and Forecast, by Application (2025-2034)
12.5.3. Market Revenue and Forecast, by Solution (2025-2034)
12.5.4. Market Revenue and Forecast, by End-user (2025-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2025-2034)
12.5.5.2. Market Revenue and Forecast, by Application (2025-2034)
12.5.5.3. Market Revenue and Forecast, by Solution (2025-2034)
12.5.5.4. Market Revenue and Forecast, by End-user (2025-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2025-2034)
12.5.6.2. Market Revenue and Forecast, by Application (2025-2034)
12.5.6.3. Market Revenue and Forecast, by Solution (2025-2034)
12.5.6.4. Market Revenue and Forecast, by End-user (2025-2034)
Chapter 13. Company Profiles
13.1. Thermo Fisher Scientific
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Sartorius AG
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Danaher Corp.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Merck KGaA
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Avantor
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Lonza
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Saint-Gobain
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Corning Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Entegris
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. KUHNER AG
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms